Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes. - Pison, Christophe; Shah, Pallav L.; Slebos, Dirk-Jan; Ninane, Vincent; Janssens, Wim; Perez, Thierry; Kessler, Romain; Deslee, Gaetan; Garner, Justin L.; Hartman, Jorine E.; Degano, Bruno; Mayr, Anna; et al. (Respiratory Research, 2021)